Doyle M Cummings1, Alyssa Adams2, Shivajirao Patil2, Andrea Cherrington3, Jacqueline R Halladay4, Suzanne Oparil3, Orysya Soroka5, Joanna Bryan Ringel5, Monika M Safford5. 1. Departments of Public Health and Family Medicine, Brody School of Medicine, East Carolina University, 115 Heart Drive, Greenville, NC, 27834-8982, USA. cummingsd@ecu.edu. 2. Departments of Public Health and Family Medicine, Brody School of Medicine, East Carolina University, 115 Heart Drive, Greenville, NC, 27834-8982, USA. 3. Divisions of Preventive Medicine and Cardiovascular Disease, University of Alabama-Birmingham, Birmingham, AL, USA. 4. Department of Family Medicine, University of North Carolina, Chapel Hill, NC, USA. 5. Division of General Internal Medicine, Weill Cornell Medical Center, New York, NY, USA.
Abstract
BACKGROUND/ OBJECTIVE: Because racial disparities in hypertension treatment persist, the objective of the present study was to examine patient vs. practice characteristics that influence antihypertensive selection and treatment intensity for non-Hispanic Black (hereafter "Black") patients with uncontrolled hypertension in the rural southeastern USA. METHODS: We enrolled 25 Black patients from each of 69 rural practices in Alabama and North Carolina with uncontrolled hypertension (systolic blood pressure (BP) ≥ 140 mm Hg) in a 4-arm cluster randomized trial of BP control interventions. Patients' antihypertensive medications were abstracted from medical records and reconciled at the baseline visit. Treatment intensity was computed using the defined daily dose (DDD) method of the World Health Organization. Correlates of greater antihypertensive medication intensity were assessed by linear regression modeling, and antihypertensive medication classes were compared by baseline systolic BP (SBP) level. RESULTS: A total of 1431 patients were enrolled and had complete baseline data. Antihypertensive treatment intensity averaged 3.7 ± 2.6 equivalent medications at usual dosages and was significantly related to higher baseline systolic BP, older age, male sex, insurance availability, higher BMI, and concurrent diabetes, but not to practice type or medication barriers in regression models. Renin-angiotensin system inhibitors were the most commonly used medications, followed by diuretics and calcium channel blockers. CONCLUSION/RELEVANCE: Antihypertensive treatment intensity for Black patients in the rural southeastern USA with a history of uncontrolled hypertension averaged the equivalent of almost four medications at usual dosages and was significantly associated with baseline SBP levels and other patient characteristics, but not clinic type. TRIAL REGISTRATION: ClinicalTrials.gov NCT02866669.
BACKGROUND/ OBJECTIVE: Because racial disparities in hypertension treatment persist, the objective of the present study was to examine patient vs. practice characteristics that influence antihypertensive selection and treatment intensity for non-Hispanic Black (hereafter "Black") patients with uncontrolled hypertension in the rural southeastern USA. METHODS: We enrolled 25 Black patients from each of 69 rural practices in Alabama and North Carolina with uncontrolled hypertension (systolic blood pressure (BP) ≥ 140 mm Hg) in a 4-arm cluster randomized trial of BP control interventions. Patients' antihypertensive medications were abstracted from medical records and reconciled at the baseline visit. Treatment intensity was computed using the defined daily dose (DDD) method of the World Health Organization. Correlates of greater antihypertensive medication intensity were assessed by linear regression modeling, and antihypertensive medication classes were compared by baseline systolic BP (SBP) level. RESULTS: A total of 1431 patients were enrolled and had complete baseline data. Antihypertensive treatment intensity averaged 3.7 ± 2.6 equivalent medications at usual dosages and was significantly related to higher baseline systolic BP, older age, male sex, insurance availability, higher BMI, and concurrent diabetes, but not to practice type or medication barriers in regression models. Renin-angiotensin system inhibitors were the most commonly used medications, followed by diuretics and calcium channel blockers. CONCLUSION/RELEVANCE: Antihypertensive treatment intensity for Black patients in the rural southeastern USA with a history of uncontrolled hypertension averaged the equivalent of almost four medications at usual dosages and was significantly associated with baseline SBP levels and other patient characteristics, but not clinic type. TRIAL REGISTRATION: ClinicalTrials.gov NCT02866669.
Authors: John M Flack; Domenic A Sica; George Bakris; Angela L Brown; Keith C Ferdinand; Richard H Grimm; W Dallas Hall; Wendell E Jones; David S Kountz; Janice P Lea; Samar Nasser; Shawna D Nesbitt; Elijah Saunders; Margaret Scisney-Matlock; Kenneth A Jamerson Journal: Hypertension Date: 2010-10-04 Impact factor: 10.190
Authors: Rodrigo Modolo; Ana Paula de Faria; Alessandra M V Ritter; Antonio Coca; Heitor Moreno Journal: Int J Cardiol Date: 2015-09-28 Impact factor: 4.164
Authors: Jackson T Wright; J Kay Dunn; Jeffrey A Cutler; Barry R Davis; William C Cushman; Charles E Ford; L Julian Haywood; Frans H H Leenen; Karen L Margolis; Vasilios Papademetriou; Jeffrey L Probstfield; Paul K Whelton; Gabriel B Habib Journal: JAMA Date: 2005-04-06 Impact factor: 56.272
Authors: E J Parra; A Marcini; J Akey; J Martinson; M A Batzer; R Cooper; T Forrester; D B Allison; R Deka; R E Ferrell; M D Shriver Journal: Am J Hum Genet Date: 1998-12 Impact factor: 11.025
Authors: Paul A James; Suzanne Oparil; Barry L Carter; William C Cushman; Cheryl Dennison-Himmelfarb; Joel Handler; Daniel T Lackland; Michael L LeFevre; Thomas D MacKenzie; Olugbenga Ogedegbe; Sidney C Smith; Laura P Svetkey; Sandra J Taler; Raymond R Townsend; Jackson T Wright; Andrew S Narva; Eduardo Ortiz Journal: JAMA Date: 2014-02-05 Impact factor: 56.272
Authors: Jordan B King; Laura C Pinheiro; Joanna Bryan Ringel; Adam P Bress; Daichi Shimbo; Paul Muntner; Kristi Reynolds; Mary Cushman; George Howard; Jennifer J Manly; Monika M Safford Journal: Hypertension Date: 2021-11-17 Impact factor: 10.190
Authors: Stephen K Williams; Joseph Ravenell; Sara Seyedali; Sam Nayef; Gbenga Ogedegbe Journal: Prog Cardiovasc Dis Date: 2016-09-29 Impact factor: 8.194
Authors: Megan M Shuey; Jocelyn S Gandelman; Cecilia P Chung; Hui Nian; Chang Yu; Joshua C Denny; Nancy J Brown Journal: BMJ Open Date: 2018-06-27 Impact factor: 2.692